Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site‐Specific Integration of CFTR and Mutation‐Agnostic Disease Rescue

Journal:

Advanced Functional Materials

Published:

2026-01-04

DOI:

10.1002/adfm.202502540

Affiliations:

6

Authors:

13

Go to article

Institutions	Authors	Share
University of California, Los Angeles (UCLA), United States of America (USA)	5.833333	0.45
UCLA Health, United States of America (USA)	4.166667	0.32
Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), United States of America (USA)	2.000000	0.15
Department of Pediatrics, UC San Diego, United States of America (USA)	1.000000	0.08

Interested in Medical Biotechnology?